Policy & Regulation
Inspire takes the first quantified WISeR hit as Medicare bifurcates its neuromodulation posture
Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.